Sangamo BioSciences | SGMO - Ebitda





Ebitda Veränderung Datum
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 3.86B 1.28B 2026-03
Bayer EUR 2.14B 2.31B 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.01B 18M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06